COST-EFFECTIVENESS ANALYSIS OF PACLITAXEL AND CISPLATINUM VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN AS FIRST-LINE THERAPY IN ADVANCED OVARIAN-CANCER - A EUROPEAN PERSPECTIVE

Authors
BERGER K SZUCS T
Citation
K. Berger et T. Szucs, COST-EFFECTIVENESS ANALYSIS OF PACLITAXEL AND CISPLATINUM VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN AS FIRST-LINE THERAPY IN ADVANCED OVARIAN-CANCER - A EUROPEAN PERSPECTIVE, European journal of cancer, 33, 1997, pp. 2-2
Citations number
NO
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
9
Pages
2 - 2
Database
ISI
SICI code
0959-8049(1997)33:<2:CAOPAC>2.0.ZU;2-5